MAP.AX · MICROBA LIFE SCIENCES LIMITED
Australia · RS rating 37 · As of 2026-10-14
| Price | 0.05 AUD |
|---|---|
| 1-day change | -4.0% |
| RS rating (overall / 1M / 3M / 12M) | 37 / 29 / 76 / 32 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 27 / 26 / 24 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +52.0% |
| Market cap (USD) | $25.4M |